The CCKA receptor antagonist SR 27897 differentially influences the activity of A9 and A10 dopaminergic neurons in the rat

Ann N Y Acad Sci. 1994 Mar 23:713:364-7. doi: 10.1111/j.1749-6632.1994.tb44094.x.
No abstract available

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Apomorphine / pharmacology
  • Benzodiazepinones / pharmacology
  • Devazepide
  • Dopamine / metabolism*
  • Indoleacetic Acids / pharmacology*
  • Male
  • Mesencephalon / drug effects
  • Mesencephalon / physiology*
  • Neurons / drug effects
  • Neurons / physiology*
  • Rats
  • Rats, Sprague-Dawley
  • Receptors, Cholecystokinin / antagonists & inhibitors*
  • Sincalide / pharmacology*
  • Thiazoles / pharmacology*

Substances

  • Benzodiazepinones
  • Indoleacetic Acids
  • Receptors, Cholecystokinin
  • Thiazoles
  • SR 27897
  • Devazepide
  • Sincalide
  • Apomorphine
  • Dopamine